Home » NinePoint Medical Secures FDA Clearance for NvisionVLE Imaging System
NinePoint Medical Secures FDA Clearance for NvisionVLE Imaging System
The FDA has granted 510(k) clearance to NinePoint to commercialize its new real-time targeting feature on its NvisionVLE imaging system, the Boston, Mass.-based company announced Tuesday.
The system uses optical coherence tomography — an ultrasound-like technology that uses infrared light rather than sound waves — to conduct volumetric laser endomicroscopy procedures that can yield cross-sectional images in real-time.
The new feature may improve diagnosis, thus resulting in better treatment options for patients, according to the company. — Anisa Jibrell
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May